Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations

This publication has 50 references indexed in Scilit:

• Mutations inPTPN11 are rare in adult myelodysplastic syndromes and acute myeloid leukemia
  American Journal of Hematology, 2004
• Somatic inactivation of Nf1 in hematopoietic cells results in a progressive myeloproliferative disorder
  Blood, 2004
• Mutations in PTPN11 implicate the SHP-2 phosphatase in leukemogenesis
  Blood, 2004
• Mutations in PTPN11 are uncommon in adult myelodysplastic syndromes and acute myeloid leukaemia
  British Journal of Haematology, 2004
• Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation
  Human Mutation, 2004
• Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia
  Leukemia, 2003
• Identification of RUNX1/AML1 as a classical tumor suppressor gene
  Oncogene, 2003
• NF1 gene analysis based on DHPLC
  Human Mutation, 2003
• Hematologic malignancies
  Current Opinion in Hematology, 2001
• A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome
  Nature, 1987